表紙
市場調查報告書

全球動物用醫藥品市場

Animal Medication

出版商 Global Industry Analysts, Inc. 商品編碼 248891
出版日期 內容資訊 英文 393 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球動物用醫藥品市場 Animal Medication
出版日期: 2018年09月01日內容資訊: 英文 393 Pages
簡介

本報告提供全球動物用醫藥品市場相關調查,市場現狀與今後的成長預測,各地區趨勢,及加入此市場的主要企業的簡介等資料彙整。

第1章 簡介,調查方法,定義

第2章 市場預測

  • 動物醫療的重要性
  • 寵物的一般的疾病
  • 動物用蛋白質的需求擴大與寵物擁有的增加促進動物用醫藥品市場
  • 近幾年接受FDA的認證的動物用醫藥品
  • 產業趨勢
  • 已開發國家領先,發展中國家也氣勢漸增
  • 家畜動物:最大市場類別
  • 寄生蟲驅除劑
  • 動物用疫苗牽引市場成長
  • 抗感染藥

第3章 市場趨勢和動態

  • 寵物擁有的增加與支出牽引需求
  • 寵物:收益性高的市場市場區隔
  • 未滿足需求推動成長
  • 在發展中國家的動物用蛋白質的需求擴大 其他

第4章 動物用疫苗市場:概要

  • 動物用疫苗市場高成長預定
  • 人口統計差異和市場課題
  • 新興技術促進成本效益
  • 重組的DNA技術促進產業、其他

第5章 產品概要

  • 簡介
  • 預防用醫藥品
  • 治療用醫藥品
  • 寵物的醫藥品需求
  • 一般的處方藥
  • 動物用醫藥品的種類 其他

第6章 法律規章的制度

  • 美國
  • 歐洲
  • 巴西
  • 澳洲
  • 其他

第7章 競爭環境

  • 主要企業
  • 產品上市/認證
  • 近幾年的產業活動

第8章 全球市場預測

第9章 各地區市場預測

  • 美國
  • 加拿大
  • 日本
  • 歐洲
  • 亞太地區
  • 南美
  • 其他

第10章 企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-6975

This report analyzes the worldwide markets for Animal Medication in US$ Million by the following End-Use Segments: Companion Animals, and Farm Animals. The Global market is further analyzed by the following Product Groups: Parasiticides, Vaccines, Anti-Infectives, Medicinal Feed Additives, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 105 companies including many key and niche players such as -

Bayer AG
Boehringer Ingelheim International GmbH
Ceva Sante Animale S.A.
Dechra Pharmaceuticals PLC
Eli Lilly and Company
Merck Animal Health

Table of Contents

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Data interpretation & reporting level
  • Quantitative techniques & analytics
  • Product definitions and scope of study

2. MARKET OUTLOOK

  • Importance of Animal Health: A Prelude
  • Common Diseases in Companion Animals
  • Growing Demand for Animal Protein and Rising Pet Ownership Drives Animal Medication Market
  • Recent FDA Approved Animal Medication: 2018
  • Industry Dynamics
  • Developed Regions Ahead; Developing Markets Gathering Momentum
  • Farm Animals - The Largest Market Category
  • Parasiticides Stay in the Lead
  • Veterinary Vaccines Drive Market Growth
  • Anti-Infectives: Also a Significant Market Segment

3. MARKET TRENDS & DYNAMICS

  • Growing Pet Ownership and Spending Drives Demand
    • Table 1: Global Pet Dog Population (2017): Number of Pet Dogs by Select Countries (in Millions) (includes corresponding Graph/Chart)
    • Table 2: Global Pet Cat Population (2017): Number of Pet Cats by Select Countries (in Millions) (includes corresponding Graph/Chart)
    • Table 3: Global Pet Birds Population (2017): Number of Pet Birds by Select Countries (in Millions) (includes corresponding Graph/Chart)
    • Table 4: Global Pet Fish Population (2017): Number of Pet Fish by Select Countries (in Millions) (includes corresponding Graph/Chart)
  • Companion Animals: A High Value Lucrative Market Segment
  • Need to Reduce the Foot Print of Food Production Drives Gains
  • Spread of Zoonotic Diseases Propels Growth
  • Unmet Animal Health Needs Drives Growth
  • Need to Ensure Sustainable Food Supply Spurs Growth
  • Increasing Demand for Animal Protein in Developing Countries to Benefit the Market
  • Opportunity Indicators
    • Table 5: Top Countries Worldwide in Terms of Population (July 2018) (in Million) (includes corresponding Graph/Chart)
    • Table 6: Worldwide Protein Consumption (kt): 2016-2020 (includes corresponding Graph/Chart)
    • Table 7: Per Capita Meat Consumption for Select Countries (In LB/per capita): 2017 (includes corresponding Graph/Chart)
  • Growing Trend of Human Drug Pharmacies Dispensing Veterinary Medications
  • Flavored Veterinary Medications Registers Notable Growth
  • Safety Concerns: An Opportunity Generator
  • Healthy Investments in Veterinary Pharmaceuticals Drive Growth
  • Role of Pharmacokinetics in Animal Drug Development
  • Animal Health Market Expected to Gain from Antimicrobial Resistance
  • Responsible use of Animal Medicines Ignites Interest in Herbal Alternatives
  • Will the Growing Support for Hormone and Antibiotic Free Animal Produce Impact the Growth Prospects of the Animal Medicine?
  • Veterinarians Loose Share to New Channels
  • Exclusive Animal Drugs Foray into Human Pharmacies
  • Rising 'Gray' Market Sales for Animal Health Drugs
  • Growing Momentum for Post Slaughter Strategies Bodes well for Animal Medicine
  • Demand for Metabolic Modifiers Surging
  • Genomics to Influence Development of Animal Medicine in the Future
  • Nanotechnology Fast Gaining Ground in Animal Medicine
  • Animal Drug Distribution and Dispensing Sees Transformation - A Growing Threat to Veterinarians
  • Generic Insurgency in Animal Health Market - Not As Strong As in Human Health
  • Human Drugs Continue to Permeate Animal Drug Market, Manufacturers Queue in to Capitalize on Growing Prospects
  • Managing a Portfolio of Drugs - Key to Business Risk Aversion
  • Aquaculture Medicines - A Growing Niche in the Animal Medication Market

4. VETERINARY VACCINES MARKET - AN OVERVIEW

  • Veterinary Vaccine Market on a High Growth Track
    • Table 8: Worldwide Veterinary Vaccines by Technology (2017): Including Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vector Vaccines, Toxoid Vaccines, and DNA Vaccines (includes corresponding Graph/Chart)
  • Veterinary Vaccines Market - Demographic Differences and Market Challenges
  • Emerging Technology Enhances Cost Effectiveness of Veterinary Vaccines
  • Recombinant DNA Technology Boosts the Animal Vaccine Industry
  • Pricing Affects Livestock Medication Market
  • The Need for Innovative Vaccine Delivery Mechanism Increasing
  • Egg-Derived Veterinary Vaccines in Human Vaccine Facilities
  • Will Plant-Derived Vaccines Hold Potential in Animal Health Care Industry?
  • More Vaccines Needed to Prevent Zoonotic Infections
  • Parasitic Vaccines Segment Holds Potential
  • Marker Vaccines Playing a Vital Role in Disease Detection

5. PRODUCT OVERVIEW

  • Animal Medication: An Introduction
  • Preventive Medicines
  • Therapeutic Medicines
  • Others
  • Considerations
  • Need for Medications in Companion Animals
  • Commonly Prescribed (Rx) Animal Health Medications
  • Non-Prescription Medications
  • Types of Non-Prescription Medications
  • Types of Animal Medication
  • Parasiticides
  • Veterinary Vaccines
    • Classification of Veterinary Vaccines
      • Companion Animals Vaccines
      • Canine Vaccines
      • Feline Vaccines
      • Livestock Vaccines
      • A Tabular Analysis on Select Animal Diseases Controlled by Vaccines
  • Anti-infectives
  • Medicinal Feed Additives
  • Others

6. REGULATORY REGIME

  • United States
  • United States Food and Drug Administration (FDA)
  • United States Department of Agriculture (USDA)
  • Environmental Protection Agency (EPA)
  • European Union
  • Brazil
  • Australia
  • Rest of World
  • Global Policy & Guidance
  • Joint FAO/WHO Expert Committee on Food Additives
  • Food Safety Inspection Service
  • Promotion & Advertising Review
  • VICH Program

7. COMPETITIVE LANDSCAPE

    • Table 9: Global Animal Medication Market by Leading Players (2017): Market Share Breakdown of Revenues for Zoetis, Merck, Boehringer Ingelheim, Eli Lilly and Company (USA), Bayer-Animal Health, Ceva, Vetoquinol SA (France), and Others (includes corresponding Graph/Chart)
    • Table 10: Select Leading Animal Health Medication of Major Global Players: 2017 (includes corresponding Graph/Chart)
  • Market Ripe for Consolidation
  • Zoetis - The Industry Leader
  • Leading Distributors of Animal Health Products
  • 7.1 Focus on Select Global Players
  • Bayer AG (Germany)
  • Boehringer Ingelheim International GmbH (Germany)
  • Ceva Sante Animale S.A. (France)
  • Dechra Pharmaceuticals PLC (UK)
  • Eli Lilly and Company (USA)
  • Merck Animal Health (Netherlands)
  • Vetericyn, Inc. (USA)
  • Vetoquinol SA (France)
  • Virbac SA (France)
  • Zoetis, Inc. (USA)
  • 7.2 Product Launches/Approvals
  • Boehringer Ingelheim Introduces Liquid Solution to Treat Hypertension in Cats
  • Boehringer Ingelheim Extends European Metacam(r) Indication to Guinea Pigs
  • Elanco Animal Health Launches Novel respiratory PRRS vaccine
  • Merck Animal Health Launches Updated Equine Influenza Vaccines
  • Hipra Introduces Smart Vaccination Range for Total Vaccination Control
  • Boehringer Ingelheim, KMOH, and ZNWT Join Hands to Introduce World-Class Vaccine Joint Venture in China
  • Boehringer Introduces Recombitek Oral Bordetella
  • Zoetis Introduces Vanguard(r) CIV H3N2/H3N8 Vaccine
  • HIPRA Launches ERYSENG(r) PARVO in Canada
  • MSD Animal Health Introduces EXZOLT(r)
  • MSD Animal Health Introduces INNOVAX(r)-ND-IBD
  • Aptimmune Introduces World's First Mucosal PRRSV Vaccine
  • Norbrook Introduces Carprieve(r) Chewable Tablets for Dogs
  • AgriLabs Progresses Announces the Commercialization of DNA vaccine platform
  • HIPRA Introduces STARTVAC(r) in Korea
  • Ivaoes Animal Health Launches Rapanofal
  • Elanco in Partnership with Aratana Introduces Veterinary Pain Drug
  • CytoSorbents Introduces VetResQ in the US
  • Dechra Veterinary Products to Launch Zycortal in the UK
  • Zoetis Obtains Conditional License from USDA for Avian Influenza Vaccine
  • Zoetis Rolls Out CLARIFIDE(r) Plus Genomic Test for Holstein Cattle
  • Zoetis Obtains FDA Approval for Simparica(tm)
  • Merck Animal Health Introduces Safe-Guard(r) AquaSol for Ascaridia galli Treatment in Chicken
  • Bionaturis Introduces Five New Developmental Stage Animal Health Biotech Products
  • Merck Animal Health Obtains EC Approval for PORCILIS(r) PCV ID Vaccine
  • Bayer Obtains Approval for Claro(tm) for Treating Otitis Externa in Canines
  • Boehringer Ingelheim Rolls Out New Swine Vaccines for PRRS in Europe
  • Merial Launches Tablet Vaccine for NDV Prevention
  • Bayer Introduces Immunostimulant Zelnate(r) for Reducing Bovine Respiratory Disease
  • Merck Animal Health Launches INNOVAX(r)-ILT in EU
  • Merck Animal Health Rolls Out FORTEGRA(r) Vaccine in Latin America
  • Elanco Launches Canine Otitis Externa Treatment Medication - Osurnia(r)
  • Ceva Animal Health Rolls Out Canine Heart Failure Management Medication - Libeo
  • Dechra Veterinary Products Rolls Out 5 ml Bottle Dosage of Comfortan(r)
  • Merck Animal Health Launches AQUAVAC(r) PD3 Vaccine for Salmon
  • Innovacyn Launches Improved Vetericyn(r) Plus Medications for Beef Cattle and Dairy
  • Merck Animal Health Rolls Out PORCILIS(r) PCV M Hyo in Europe
  • 7.3 Recent Industry Activity
  • Animalcare Group PLC Completes the Selling of the Medini NV Unit
  • Huvepharma Completes the Acquisition of T-HEXX Animal Health
  • PHARMAQ Agrees with Vinh Hoan to Improve Fish Health in Vietnam
  • Eli Global Acquires Stratford Pharmaceuticals, LLC
  • CordenPharma Plans to Invest in New Veterinary Drug Products Manufacturing Line
  • Zoetis Acquires Abaxis
  • Lilly Plans to Divest Elanco Animal Health
  • Boehringer Ingelheim Plans to Establish Strategic Production Center in France for Veterinary Public Health
  • Bayer Animal Health Signs a Licensing Agreement with Mitsui Chemicals Agro
  • Seresto(r) Receives New Licensing in Many European Countries
  • MSD Animal Health Partners With Vinovo to Enhance Poultry Health
  • Regeneron Collaborates with Zoetis to Research Monoclonal Antibody Therapies
  • Oasmia Pharmaceutical Spins-off Veterinary Oncology Assets
  • Dechra Plans to Buy AST Farma, Le Vet
  • Agrovet Market Animal Health Completes the Acquisition of Pharmadix Laboratories
  • Zoetis Plans to Expand Animal Vaccine Research and Manufacturing in Suzhou, China
  • Henry Schein Inc and Vets First Choice Plans to Spin-off Animal Health Business Unit
  • Elanco Animal Health Receives FDA Approval for Credelio(r) (lotilaner)
  • Huvepharma Acquires AgriLabs
  • PetIQ, Inc. Agrees to Acquire VIP Petcare
  • Merck Animal Health Acquires Prondil S.A.
  • MSD Animal Health Partners with Laboratorios LETI to Distribute LetiFend(r) Vaccine
  • MSD Animal Health Plans to Acquire Vilsan Pharmaceuticals
  • Vets First Choice Completes Two Strategic Acquisitions
  • Henry Schein Plans to Acquire Merritt Veterinary Supplies
  • MSD Animal Health Plans to Purchase Manufacturing Facility in Krems, Austria
  • Zoetis Acquires Nexvet Biopharma
  • Bayer Invests in Animal Health Production
  • Zoetis Plans to Expand Manufacturing Capacity in Kalamazoo
  • Zoetis Receives Marketing Authorization for Cytopoint(r) in Europe
  • Fresenius Kabi Plans to Acquire Akorn
  • Merck Animal Health Acquires Vallee S.A.
  • Elanco Animal Health Acquires Boehringer Ingelheim Vetmedica's U.S. Feline, Canine and Rabies Vaccines Portfolio
  • Ceva Signs an Agreement with EBVAC for Creating a New Business Unit
  • Zoetis Receives Approval for Stronghold(r) Plus from European Commission
  • Ceva Acquires Merial Swine & Cattle Vaccines and Nonsteroidal Anti-Inflammatories Portfolio from Boehringer Ingelheim
  • IDT Biologika Completes the Acquisition of Ridgeway Biologicals Ltd.
  • PHARMAQ Acquires Nordland Sett Vaks
  • Sanofi and Boehringer Ingelheim Closes Strategic Transaction
  • Harrisvaccine' RNA Particle Vaccine Platform Obtains USDA Licensure
  • Ceva Acquires India-based Polchem
  • Merial and Zoetis Ink Marketing and Distribution Agreement for Dairy Vaccines and Medicines in India
  • Huvepharma Acquires Zoetis' Longmont Facility
  • Zydus Cadila Acquires Select Assets of Zoetis in India
  • Sanofi and Boehringer Ingelheim Ink Business Swap Agreement
  • Merck Animal Health Receives Conditional License for New Canine Influenza Vaccine
  • Merck Animal Health to Acquire Harrisvaccines
  • Zoetis Takes Over PHARMAQ
  • Merck Animal Health Announces New Indication for FINADYNE(r) Transdermal Solution
  • Zoetis Receives Conditional License from USDA for Canine Atopic Dermatitis Immunotherapeutic
  • Zoetis Obtains Registration for Equivac(r) HeV from APVMA
  • Zoetis Completes Expansion at Lincoln, Nebraska-based Facility
  • Merck Animal Health and China Animal Husbandry Industry ink MoU
  • Merck Animal Health Registers Two Vaccines in Vietnam
  • Merial Acquires Equine Products LEGEND(r) and MARQUIS(r) from Bayer
  • Zoetis Acquires Abbott's Animal Health Assets
  • Dechra Renames Fucithalmic(r) Vet Eye Medicines as Isathal(r)

8. GLOBAL MARKET PERSPECTIVE

    • Table 11: World Recent Past, Current and Future Analysis for Animal Medication by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 12: World Historic Review for Animal Medication by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 13: World 14-Year Perspective for Animal Medication by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2018, and 2024 (includes corresponding Graph/Chart)
    • Table 14: World Recent Past, Current and Future Analysis for Companion Animal Medication by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 15: World Historic Review for Companion Animal Medication by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 16: World 14-Year Perspective for Companion Animal Medication by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2018, and 2024 (includes corresponding Graph/Chart)
    • Table 17: World Recent Past, Current and Future Analysis for Farm Animal Medication by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 18: World Historic Review for Farm Animal Medication by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 19: World 14-Year Perspective for Farm Animal Medication by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2018, and 2024 (includes corresponding Graph/Chart)
    • Table 20: World Recent Past, Current and Future Analysis for Farm Animal Medication by Animal Type - Cattle, Pigs, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 21: World Historic Review for Farm Animal Medication by Animal Type - Cattle, Pigs, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 22: World 14-Year Perspective for Farm Animal Medication by Animal Type - Percentage Breakdown of Dollar Sales for Cattle, Pigs, and Others Markets for Years 2011, 2018, and 2024 (includes corresponding Graph/Chart)
    • Table 23: World Recent Past, Current and Future Analysis for Cattle Medication by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 24: World Historic Review for Cattle Medication by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 25: World 14-Year Perspective for Cattle Medication by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2018, and 2024 (includes corresponding Graph/Chart)
    • Table 26: World Recent Past, Current and Future Analysis for Pigs Medication by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 27: World Historic Review for Pigs Medication by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 28: World 14-Year Perspective for Pigs Medication by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2018, and 2024 (includes corresponding Graph/Chart)
    • Table 29: World Recent Past, Current and Future Analysis for Other Farm Animal Medication by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 30: World Historic Review for Other Farm Animal Medication by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 31: World 14-Year Perspective for Other Farm Animal Medication by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2018, and 2024 (includes corresponding Graph/Chart)
    • Table 32: World Recent Past, Current and Future Analysis for Animal Medication by Product Group - Parasiticides, Vaccines, Anti-Infectives, Medicinal Feed Additives and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 33: World Historic Review for Animal Medication by Product Group - Parasiticides, Vaccines, Anti-Infectives, Medicinal Feed Additives and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 34: World 14-Year Perspective for Animal Medication by Product Group - Percentage Breakdown of Dollar Sales for Parasiticides, Vaccines, Anti-Infectives, Medicinal Feed Additives and Others Markets for Years 2011, 2018, and 2024 (includes corresponding Graph/Chart)

9. REGIONAL MARKET PERSPECTIVE

  • 9.1 The United States
  • A. Market Analysis
    • Current & Future Analysis
    • Increasing Pet Ownership - An Insight
    • Table 35: Pet Ownership in the US by Household Penetration Rate (1998- 2017) (includes corresponding Graph/Chart)
    • Table 36: Pet Ownership in the US by Generation (in %): 2017 (includes corresponding Graph/Chart)
    • Table 37: Millennial Pet Ownership in the US by Gender (in %): 2017 (includes corresponding Graph/Chart)
    • Table 38: Pet Ownership in the US (2017): Number of Households that Own a Pet by Animal Type (includes corresponding Graph/Chart)
    • Table 39: US Pet Population (2017): Breakdown of Number of Pets by Category (in Millions) (includes corresponding Graph/Chart)
    • Spending on Pets Rises to New Highs, Medications Drive Growth
    • Table 40: The US Expenditure on Pets (2001-2018): Annual Expenditure in US$ Billion (includes corresponding Graph/Chart)
    • Pet Insurance on the Rise
    • Insurance Companies Galvanize Accessibility of Veterinary Innovations
    • Farm Animals Market
    • Benefits of Veterinary Feed Directive (VFD) and VCPR
    • Food Safety Concerns and Biotechnological Offerings Drive the Veterinary Vaccines Market
    • New Channels Emerge Challenging Veterinary Services' Dominance
    • Table 41: US Pet Medications Market by Distribution Channel (2017): Percentage Breakdown of Sales for Veterinarian, and Non-Veterinarian (Traditional Retail, Online and Pet Speciality) (includes corresponding Graph/Chart)
      • Prescription Portability Gains Attention as New Channels Become Popular
      • Pet Owners Stand to Gain in the Changing Drug Distribution Environment
      • Online Sales Gather Momentum
    • Significant Hurdles Exist for Generic Pet Medications
    • Food Safety Concerns and Biotechnological Offerings Drive the Veterinary Vaccines Market
    • H5N1 Virus: A Conundrum for the US Animal Medication Industry
    • Regulations
    • Animal Drug Compounding and the Legalities Behind
      • FDA's New Draft on Bulk Drug Compounding to Expand Treatment Options
  • B. Market Analytics
    • Table 42: The US Recent Past, Current and Future Analysis for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 43: The US Historic Review for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 44: The US 14-Year Perspective for Animal Medication by Category - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2011, 2018, and 2024 (includes corresponding Graph/Chart)
  • 9.2 Canada
  • A. Market Analysis
    • Current & Future Analysis
    • Overview of the Canadian Animal Health Industry
    • Imports and Manufacture of Veterinary Biologics
  • B. Market Analytics
    • Table 45: Canadian Recent Past, Current and Future Analysis for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 46: Canadian Historic Review for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 47: Canadian 14-Year Perspective for Animal Medication by Category - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2011, 2018, and 2024 (includes corresponding Graph/Chart)
  • 9.3 Japan
  • Market Analysis
    • Table 48: Japanese Recent Past, Current and Future Analysis for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 49: Japanese Historic Review for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 50: Japanese 14-Year Perspective for Animal Medication by Category - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2011, 2018, and 2024 (includes corresponding Graph/Chart)
  • 9.4 Europe
  • A. Market Analysis
    • Current & Future Analysis
    • Table 51: Pet Population in Europe: 2017 (includes corresponding Graph/Chart)
      • Committee for Medicinal Products for Veterinary Use (CVMP) Positive Opinion on Medicinal Products for Veterinary Use: 2017
    • New EU Parliamentary Regulations to Curb Antibiotic Usage in Animal Product Imports
  • B. Market Analytics
    • Table 52: European Recent Past, Current and Future Analysis for Animal Medication by Geographic Region/Country - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 53: European Historic Review for Animal Medication by Geographic Region/Country - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 54: European 14-Year Perspective for Animal Medication by Geographic Region/Country - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2011, 2018, and 2024 (includes corresponding Graph/Chart)
    • Table 55: European Recent Past, Current and Future Analysis for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 56: European Historic Review for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 57: European 14-Year Perspective for Animal Medication by Category - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2011, 2018, and 2024 (includes corresponding Graph/Chart)
  • 9.4.1 France
  • A. Market Analysis
    • Current & Future Analysis
    • France - A Leading Nation in Veterinary Medicine R&D
  • B. Market Analytics
    • Table 58: French Recent Past, Current and Future Analysis for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 59: French Historic Review for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 60: French 14-Year Perspective for Animal Medication by Category - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2011, 2018, and 2024 (includes corresponding Graph/Chart)
  • 9.4.2 Germany
  • A. Market Analysis
    • Current & Future Analysis
    • Pet Population in Germany
    • Table 61: Pet Population in Germany by Type: 2017 (in Million) (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 62: German Recent Past, Current and Future Analysis for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 63: German Historic Review for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 64: German 14-Year Perspective for Animal Medication by Category - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2011, 2018, and 2024 (includes corresponding Graph/Chart)
  • 9.4.3 Italy
  • Market Analysis
    • Table 65: Italian Recent Past, Current and Future Analysis for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 66: Italian Historic Review for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 67: Italian 14-Year Perspective for Animal Medication by Category - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2011, 2018, and 2024 (includes corresponding Graph/Chart)
  • 9.4.4 The United Kingdom
  • A. Market Analysis
    • Current & Future Analysis
    • Key Statistics
      • Pet Population in the UK
    • Table 68: Pet Population in the UK by Type (2017) (In Million) (includes corresponding Graph/Chart)
    • Table 69: Percentage of Households with Pet in the UK by Pet Type (2017) (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 70: The UK Recent Past, Current and Future Analysis for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 71: The UK Historic Review for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 72: The UK 14-Year Perspective for Animal Medication by Category - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2011, 2018, and 2024 (includes corresponding Graph/Chart)
  • 9.4.5 Spain
  • Market Analysis
    • Table 73: Spanish Recent Past, Current and Future Analysis for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 74: Spanish Historic Review for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 75: Spanish 14-Year Perspective for Animal Medication by Category - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2011, 2018, and 2024 (includes corresponding Graph/Chart)
  • 9.4.6 Russia
  • Market Analysis
    • Table 76: Russian Recent Past, Current and Future Analysis for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 77: Russian Historic Review for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 78: Russian 14-Year Perspective for Animal Medication by Category - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2011, 2018, and 2024 (includes corresponding Graph/Chart)
  • 9.4.7 Rest of Europe
  • A. Market Analysis
    • A Review of Regional Animal Vaccine Markets
      • The Netherlands
      • Denmark
  • B. Market Analytics
    • Table 79: Rest of Europe Recent Past, Current and Future Analysis for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 80: Rest of Europe Historic Review for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 81: Rest of Europe 14-Year Perspective for Animal Medication by Category - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2011, 2018, and 2024 (includes corresponding Graph/Chart)
  • 9.5 Asia-Pacific
  • Market Analysis
    • Table 82: Asia-Pacific Recent Past, Current and Future Analysis for Animal Medication by Geographic Region/Country - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 83: Asia-Pacific Historic Review for Animal Medication by Geographic Region/ Country - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 84: Asia-Pacific 14-Year Perspective for Animal Medication by Geographic Region/ Country - Percentage Breakdown of Dollar Sales for China, India and Rest of Asia-Pacific Markets for Years 2011, 2018, and 2024 (includes corresponding Graph/Chart)
    • Table 85: Asia-Pacific Recent Past, Current and Future Analysis for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 86: Asia-Pacific Historic Review for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 87: Asia-Pacific 14-Year Perspective for Animal Medication by Category - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2011, 2018, and 2024 (includes corresponding Graph/Chart)
  • 9.5.1 China
  • A. Market Analysis
    • Current & Future Analysis
    • Growing Pet Industry Holds Promise
    • Increased Livestock Output Lead to Higher Vaccine Demand
    • Threat of Avian Influenza Outbreaks Creates Market for Effective Vaccine
    • Demand for Higher-Quality Swine Fever Vaccine
    • Demand for Effective PRRS Vaccines by Foreign Manufacturers
    • Highly Consolidated Chinese Animal Vaccine Market
  • B. Market Analytics
    • Table 88: Chinese Recent Past, Current and Future Analysis for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 89: Chinese Historic Review for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 90: Chinese 14-Year Perspective for Animal Medication by Category - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2011, 2018, and 2024 (includes corresponding Graph/Chart)
  • 9.5.2 India
  • A. Market Analysis
    • Current & Future Analysis
    • Animal Vaccination Market Scenario
    • Major Players
  • B. Market Analytics
    • Table 91: Indian Recent Past, Current and Future Analysis for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 92: Indian Historic Review for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 93: Indian 14-Year Perspective for Animal Medication by Category - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2011, 2018, and 2024 (includes corresponding Graph/Chart)
  • 9.5.3 Rest of Asia-Pacific
  • A. Market Analysis
    • Current & Future Analysis
    • Review of Select Markets
      • Australia
      • A Note on Australian Veterinary Therapeutics Market
      • Taiwan
      • Taiwan's Animal Healthcare Industry under Scan
  • B. Market Analytics
    • Table 94: Rest of Asia-Pacific Recent Past, Current and Future Analysis for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 95: Rest of Asia-Pacific Historic Review for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 96: Rest of Asia-Pacific 14-Year Perspective for Animal Medication by Category - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2011, 2018, and 2024 (includes corresponding Graph/Chart)
  • 9.6 Latin America
  • Market Analysis
    • Table 97: Latin American Recent Past, Current and Future Analysis for Animal Medication by Geographic Region/Country - Brazil, Mexico and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 98: Latin American Historic Review for Animal Medication by Geographic Region/Country - Brazil, Mexico and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 99: Latin American 14-Year Perspective for Animal Medication by Geographic Region/ Country - Percentage Breakdown of Dollar Sales for Brazil, Mexico and Rest of Latin America Markets for Years 2011, 2018, and 2024 (includes corresponding Graph/Chart)
    • Table 100: Latin American Recent Past, Current and Future Analysis for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 101: Latin American Historic Review for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 102: Latin American 14-Year Perspective for Animal Medication by Category - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2011, 2018, and 2024 (includes corresponding Graph/Chart)
  • 9.6.1 Brazil
  • Market Analysis
    • Table 103: Brazilian Recent Past, Current and Future Analysis for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 104: Brazilian Historic Review for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 105: Brazilian 14-Year Perspective for Animal Medication by Category - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2011, 2018, and 2024 (includes corresponding Graph/Chart)
  • 9.6.2 Mexico
  • Market Analysis
    • Table 106: Mexican Recent Past, Current and Future Analysis for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 107: Mexican Historic Review for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 108: Mexican 14-Year Perspective for Animal Medication by Category - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2011, 2018, and 2024 (includes corresponding Graph/Chart)
  • 9.6.3 Rest of Latin America
  • Market Analysis
    • Table 109: Rest of Latin American Recent Past, Current and Future Analysis for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 110: Rest of Latin American Historic Review for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 111: Rest of Latin American 14-Year Perspective for Animal Medication by Category - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2011, 2018, and 2024 (includes corresponding Graph/Chart)
  • 9.7 Rest of World
  • Market Analysis
    • Table 112: Rest of World Recent Past, Current and Future Analysis for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 113: Rest of World Historic Review for Animal Medication by Category - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 114: Rest of World 14-Year Perspective for Animal Medication by Category - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2011, 2018, and 2024 (includes corresponding Graph/Chart)

10. COMPANY PROFILES Total Companies Profiled: 105 (including Divisions/Subsidiaries - 124) The United States (48) Canada (2) Japan (1) Europe (39) - France (3) - Germany (7) - The United Kingdom (8) - Italy (2) - Spain (3) - Rest of Europe (16) Asia-Pacific (Excluding Japan) (26) Middle East (3) Latin America (5)

Back to Top